Hengrui Medicine (01276.HK): HRS-3095 tablets approved for clinical trials.

Wisdom Financial News App News, Hengrui Medicine (01276.HK) announced that recently, its subsidiary Chengdu Shengdi Medicine Co., Ltd. received the Drug Clinical Trial Approval Notice issued by the National Medicines Supervision Administration (referred to as the "National Drug Supervision Administration"), and will soon carry out clinical trials for HRS-3095 tablets.